Home/Filings/4/0001209191-23-017383
4//SEC Filing

Lynch Richard D. 4

Accession 0001209191-23-017383

CIK 0000004447other

Filed

Mar 7, 7:00 PM ET

Accepted

Mar 8, 7:56 PM ET

Size

36.1 KB

Accession

0001209191-23-017383

Insider Transaction Report

Form 4
Period: 2023-03-06
Lynch Richard D.
Senior Vice President
Transactions
  • Exercise/Conversion

    Common Stock, $1.00 par value

    2023-03-07$49.72/sh+7,226$359,27730,848 total
  • Exercise/Conversion

    Common Stock, $1.00 par value

    2023-03-07$101.17/sh+2,953$298,75526,575 total
  • Sale

    Common Stock, $1.00 par value

    2023-03-07$138.96/sh2,953$410,34923,622 total
  • Exercise/Conversion

    Option to purchase Common Stock

    2023-03-077,2260 total
    Exercise: $49.72From: 2023-03-06Exp: 2030-03-06Common Stock, $1.00 par value (7,226 underlying)
  • Exercise/Conversion

    Option to purchase Common Stock

    2023-03-073,4840 total
    Exercise: $75.04From: 2023-03-06Exp: 2031-03-06Common Stock, $1.00 par value (3,484 underlying)
  • Exercise/Conversion

    Common Stock, $1.00 par value

    2023-03-07$75.04/sh+3,484$261,43927,106 total
  • Award

    Option to purchase Common Stock

    2023-03-06+2,1012,101 total
    Exercise: $141.55From: 2024-03-06Exp: 2033-03-06Common Stock, $1.00 par value (2,101 underlying)
  • Award

    Option to purchase Common Stock

    2023-03-06+2,1022,102 total
    Exercise: $141.55From: 2026-03-06Exp: 2033-03-06Common Stock, $1.00 par value (2,102 underlying)
  • Sale

    Common Stock, $1.00 par value

    2023-03-07$138.92/sh17,713$2,460,69024,720 total
  • Sale

    Common Stock, $1.00 par value

    2023-03-07$138.94/sh7,226$1,003,98023,622 total
  • Award

    Option to purchase Common Stock

    2023-03-06+2,1012,101 total
    Exercise: $141.55From: 2025-03-06Exp: 2033-03-06Common Stock, $1.00 par value (2,101 underlying)
  • Award

    Common Stock, $1.00 par value

    2023-03-06+2,82644,248 total
  • Sale

    Common Stock, $1.00 par value

    2023-03-07$137.41/sh1,815$249,39942,433 total
  • Gift

    Common Stock, $1.00 par value

    2023-03-071,09823,622 total
  • Sale

    Common Stock, $1.00 par value

    2023-03-07$138.86/sh3,484$483,78823,622 total
  • Exercise/Conversion

    Option to purchase Common Stock

    2023-03-072,9530 total
    Exercise: $101.17From: 2023-03-06Exp: 2032-03-06Common Stock, $1.00 par value (2,953 underlying)
  • Award

    2023 Performance Share Unit

    2023-03-06+6,7116,711 total
    Exercise: $0.00Common Stock, $1.00 par value (14,093 underlying)
Footnotes (7)
  • [F1]Shares sold solely to satisfy tax withholding on vesting of shares of restricted stock.
  • [F2]The reported sales transactions were executed at prices ranging from $138.89 to $139.02. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions reported on this form were effected.
  • [F3]Common Stock acquired upon exercise of options granted under the Corporation's Long-Term Incentive Plans.
  • [F4]The reported sales transactions were executed at prices ranging from $138.90 to $139.02. The price reported above reflects the weighted average sales price.
  • [F5]This amount includes 6,510 shares held in escrow pursuant to the Corporation's Long Term Incentive Plans. The reporting person has only voting power of these shares until lapsing of the period set by the Committee administering the Plans at which time the shares plus accrued dividends will be delivered to the reporting person if the reporting person is still an employee of the Corporation.
  • [F6]Each Performance Share Unit entitles the holder to a payout of shares of Hess common stock equal to between 0% and 210% of such Performance Share Unit depending on the performance of the total shareholder return of Hess common stock compared with that of the XOP Total Return Index and the S&P 500 Total Return Index over a three year performance period ending December 31, 2025, as more particularly described in the applicable award agreement.
  • [F7]Not applicable

Issuer

HESS CORP

CIK 0000004447

Entity typeother

Related Parties

1
  • filerCIK 0001736369

Filing Metadata

Form type
4
Filed
Mar 7, 7:00 PM ET
Accepted
Mar 8, 7:56 PM ET
Size
36.1 KB